Market Cap

Haleon plc Market Capitalization:

£29.90 Billion

GBP as of July 1, 2023

US$37.99 Billion

business Haleon plc Company Profile

Haleon plc Main Stock Listing

show_chart LSE: HLN

Market Capitalization History of Haleon plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $78.54 B
MERCK Kommanditgesellschaft auf Aktien $70.69 B
Takeda Pharmaceutical Company Limited $46.59 B
Eisai Co. Ltd $17.26 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Haleon plc market cap

Date Market Cap YoY Change
Jan. 1, 2023 £28.83 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Haleon plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—Specialty & Generic
United Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic

Stocks & Indices

Haleon plc has the following listings and related stock indices.


Stock: LSE: HLN

Stock: NYSE: HLN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.